reports
Enphase Energy Expands Virtual Power Plant Support Across Europe
Enphase Energy Expands Virtual Power Plant Support Across Europe FREMONT, Calif., Oct. 13, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced expanded support for virtual power plants (VPPs) across Europe. Enphase products now enable advanced energy market steering smart grid features like one-minute data streaming, instant alerts for VPP events and system maintenance, and home solar curtailment to support grid constraints. Enphase is also expanding its support for ...
Taysha Gene Therapies Presents New Supplemental Data Analysis from Par...
Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting Previously disclosed 100% response rate across all 10 patients in Part A for pivotal trial primary endpoint of gain/regain of ≥ one natural history defined developmental milestone assessed via video-evidenced review by independent central raters New supplemental analysis of validated, structured efficacy scales provides supportive evidence of additional functional gains, with 100% of patients demonstrating multiple skill gai...
Enphase Energy Adds Smart Water Heater Control in Belgium, the Netherl...
Enphase Energy Adds Smart Water Heater Control in Belgium, the Netherlands, and Switzerland FREMONT, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the expansion of its IQ® Energy Management capabilities to include select electric water heaters in Belgium, the Netherlands, and Switzerland. The update, powered by the Enphase® IQ® Energy Router, gives homeowners more control over when and how they use energy – across solar, batteries, electric veh...
Enphase Energy Announces Conference Call to Review Third Quarter 2025 ...
Enphase Energy Announces Conference Call to Review Third Quarter 2025 Financial Results Tuesday, Oct. 28, 2025 at 4:30 p.m. Eastern Time FREMONT, Calif., Oct. 07, 2025 (GLOBE NEWSWIRE) -- . (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, announced today that it will host a conference call and webcast on Tuesday, Oct. 28, 2025 at 4:30 p.m. Eastern Time to discuss its third quarter 2025 financial results for the period ended Sept. 30, 2025. The live webcast can be accessed on the Enphase Energy Investor ...
Enphase Energy Launches IQ Battery 5P with FlexPhase in India, Enablin...
Enphase Energy Launches IQ Battery 5P with FlexPhase in India, Enabling Single-Phase and Three-Phase Backup for Homes and Small Businesses FREMONT, Calif., Oct. 06, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of the IQ® Battery 5P™ with FlexPhase for customers in India. The system provides reliable backup power and supports both single-phase and three-phase applications, serving India’s growing residential and small commercial solar markets. Three...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on October 1, 2025, the Compensation Committee of Taysha's Board of Directors granted seven new employees, in the aggregate, options to purchase 1,289,600 shares of the Company's common stock in conne...
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation a...
Taysha Gene Therapies Announces FDA Breakthrough Therapy Designation and Provides Positive Regulatory Update on TSHA-102 in Rett Syndrome Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all 12 patients treated in Part A of the REVEAL Phase 1/2 trials Finalized FDA alignment on REVEAL pivotal trial protocol and SAP following resolution of remaining clinical and statistical queries to IND application amendment; on track to begin patient enrollment in Q4 2025 Key pivotal trial design elements remain unchanged, includin...
Enphase Energy Announces Collaboration with Essent in the Netherlands
Enphase Energy Announces Collaboration with Essent in the Netherlands FREMONT, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a collaboration with Essent, one of the largest residential energy providers in the Netherlands. The collaboration enables eligible Enphase customers with solar to expand their systems with IQ® Batteries and participate in Essent’s Smart Steering program, designed to help households increase self-consumption and lower ene...
Enphase Energy Boosts Solargraf with New TPO Partner Integrations, Fas...
Enphase Energy Boosts Solargraf with New TPO Partner Integrations, Faster Proposals, Availability in Japan, and NREL Validation FREMONT, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced enhancements to its Solargraf® platform with new third-party ownership (TPO) financing integrations, faster proposals, and availability in Japan. Solargraf is an all-in-one digital proposal, design, and permitting tool that enables solar installers to create, mana...
Enphase Energy Opens Pre-Orders for Next-Generation IQ EV Charger 2 in...
Enphase Energy Opens Pre-Orders for Next-Generation IQ EV Charger 2 in the United States LAS VEGAS, Sept. 10, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today opened U.S. pre-orders for its next-generation electric vehicle (EV) charger, the . The new smart charger is designed to work seamlessly with Enphase solar and battery systems or as a powerful standalone charger. With advanced energy management features, the charger can support increased solar self-consumption, lower ...
Moody's Ratings downgrades VF Corp.'s senior unsecured notes ratings t...
Moody's Ratings (Moody's) affirmed V.F. Corporation's (VF Corp.) corporate family rating (CFR) at Ba2 and its probability of default rating (PDR) at Ba2-PD. At the same time, we downgraded the senior unsecured notes ratings to Ba3 from Ba2, senior unsecured shelf and senior unsecured MTN program rat...
Enphase Energy Unveils New IQ Bidirectional EV Charger Architecture fo...
Enphase Energy Unveils New IQ Bidirectional EV Charger Architecture for Home Backup and Grid Services FREMONT, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today unveiled its new IQ® Bidirectional EV Charger architecture for vehicle-to-home (V2H) and vehicle-to-grid (V2G) capability. The charger connects to the direct current (DC) port of the electric vehicle (EV) and lets homeowners charge their EV, power their home seamlessly during outages, and share ener...
Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters...
Enphase Energy Opens U.S. Pre-Orders for IQ9 Commercial Microinverters with GaN, Built for 480 V Three-Phase Systems LAS VEGAS, Sept. 08, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today opened U.S. pre-orders for the new IQ9N-3P™ Commercial Microinverter. This is Enphase’s first microinverter powered by advanced gallium nitride (GaN) technology and designed for three-phase 480Y/277 V (wye) grid configurations, without using external transformers. The simplifies design co...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing ...
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on September 2, 2025, the Compensation Committee of Taysha's Board of Directors granted five new employees, in the aggregate, options to purchase 225,000 shares of the Company's common stock in conne...
Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Ann...
Centessa Pharmaceuticals to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference BOSTON and LONDON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference in New York, NY. A fireside chat is scheduled for Tuesday, September 9th at 4:50 PM ET. The live audio webcast of this event, as well as an archived recording, will be avail...
Enphase Energy Announces Availability of Software to Expand IQ7 Solar ...
Enphase Energy Announces Availability of Software to Expand IQ7 Solar Systems with IQ8 Microinverters in More Global Markets FREMONT, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the availability of new software that enables homeowners with existing legacy IQ7™ Microinverter-based systems to expand their solar capacity using IQ8™ Microinverters. This software is now available in Australia, India, South Africa, and the Philippines, following it...
Enphase Energy Ships IQ Battery 10C with U.S. Domestic Content, Delive...
Enphase Energy Ships IQ Battery 10C with U.S. Domestic Content, Delivering Enhanced TPO Project Value FREMONT, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced initial shipments of the IQ® Battery 10C supplied from manufacturing facilities in the United States, delivering significant value in the growing third-party ownership (TPO) market. The IQ Battery 10C includes domestically sourced or manufactured components to help projects qualify for key ...
Enphase Energy Achieves Compliance for Europe’s New Cybersecurity Requ...
Enphase Energy Achieves Compliance for Europe’s New Cybersecurity Requirements on Wireless Devices FREMONT, Calif., Aug. 21, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced that all Enphase products subject to the European Union’s Radio Equipment Directive (RED) Article 3.3 cybersecurity requirements are certified to be in compliance with the rules. The new requirements under Article 3.3 of the RED, effective Aug. 1, 2025, introduce a cybersecurity foundation fo...
Enphase Energy Announces Second New Safe Harbor Agreement
Enphase Energy Announces Second New Safe Harbor Agreement FREMONT, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced a new safe harbor agreement with another leading solar and battery financing company that offers third-party ownership (TPO) agreements to homeowners, including leases and power purchase agreements (PPAs). This is the second agreement since the new U.S. federal budget bill was signed into law in July 2025. The agreement, signed earl...
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results an...
Taysha Gene Therapies Reports Second Quarter 2025 Financial Results and Provides Corporate Update Commenced site activation for REVEAL pivotal trial in accordance with previously aligned upon key design elements, following receipt of No Objection Letter (NOL) from Health Canada and feedback from the FDA; patient enrollment anticipated to begin in Q4 2025 High dose and low dose TSHA-102 continue to be generally well tolerated with no treatment-related SAEs or DLTs in the 12 patients treated in Part A of REVEAL Phase 1/2 trials as of August 2025 data cutoff Part A data from REVEAL Phase 1/2...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.